Christopher J. Swain

Statistics

Publications

102

Citations

6.3K

H-Index

Active since

1976

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Curtin University

University of Leicester

University of Zimbabwe

Christopher J. Swain is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, natural sciences, and medicinal chemistry.

ORCID

Publications per year

1976–2021

102

Publications

102

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Mark S. Kramer, Neal R. Cutler, John P. Feighner et al. · Science · 1998 · 1.1K citations

Medicine, Pharmacology, Psychiatry +17

The lithospheric architecture of Africa: Seismic tomography, mantle petrology, and tectonic evolution

Graham Begg, William L. Griffin, L. M. Natapov et al. · Geosphere · 2009 · 583 citations · Full text

Natural Sciences, Earth Sciences, Geophysics +17

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

F.D. Tattersall, Wayne Rycroft, B. Francis et al. · Neuropharmacology · 1996 · 211 citations

Medicine, Oncology, Pharmacology +4

Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

Tung M. Fong, Margaret A. Cascieri, H.Y. Yu et al. · Nature · 1993 · 184 citations

Life Sciences, Biochemistry, Pharmacology +14

Novel 5-HT3 antagonists. Indole oxadiazoles

Christopher J. Swain, Robert J. Baker, Clare O. Kneen et al. · Journal of Medicinal Chemistry · 1991 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

1–5 of 102